Literature DB >> 19167485

The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis.

Konstantinos A Paschos1, David Canovas, Nigel C Bird.   

Abstract

Cell adhesion molecules (CAMs) play a significant role in the metastatic potential of colorectal cancer and thus mediate the prognosis of this common malignancy. The downregulation of cadherins and catenins facilitates tumour cell detachment from the primary site, while the expression of selectins, integrins and members of the immunoglobulin superfamily may support neoplastic progression, intravasation and malignant cell attachment to foreign tissue, leading to the development of metastases. The liver is the main host organ of colorectal metastatic lesions. The process of hepatic invasion originates in the sinusoids, where non-parenchymal cells interact with metastasising ones, through the expression of numerous CAMs, following complex molecular pathways. Concurrently, the selective expression of cell adhesion molecules on different organs and endothelia, in conjunction with the presence of dissimilar adhesion ligands on various colorectal cancer cell lines, suggest that CAMs may also mediate the selection of the host organ, for the development of distant colorectal metastases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167485     DOI: 10.1016/j.cellsig.2009.01.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  68 in total

1.  Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Authors:  Peng Zhang; Scott Becka; Sonya E L Craig; David T Lodowski; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Cell Commun Adhes       Date:  2009-12

2.  Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.

Authors:  Claudia Fredolini; Francesco Meani; Alessandra Luchini; Weidong Zhou; Paul Russo; Mark Ross; Alexis Patanarut; Davide Tamburro; Guido Gambara; David Ornstein; Franco Odicino; Monica Ragnoli; Antonella Ravaggi; Francesco Novelli; Devis Collura; Leonardo D'Urso; Giovanni Muto; Claudio Belluco; Sergio Pecorelli; Lance Liotta; Emanuel F Petricoin
Journal:  AAPS J       Date:  2010-06-12       Impact factor: 4.009

3.  p42.3 promotes cell proliferation and invasion in human Renal-Cell Carcinoma.

Authors:  Pei-Hua Li; Wen-Jia Cao; Lin-Lin Mao; Hui Huang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma.

Authors:  Eric I Marks; Matthew Brennan; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Detection of differentially expressed basal cell proteins by mass spectrometry.

Authors:  Viktor Todorović; Bhushan V Desai; Richard A Eigenheer; Taofei Yin; Evangeline V Amargo; Milan Mrksich; Kathleen J Green; Melanie J Schroeder Patterson
Journal:  Mol Cell Proteomics       Date:  2009-11-30       Impact factor: 5.911

Review 6.  MACC1 - more than metastasis? Facts and predictions about a novel gene.

Authors:  Ulrike Stein; Mathias Dahlmann; Wolfgang Walther
Journal:  J Mol Med (Berl)       Date:  2009-09-30       Impact factor: 4.599

7.  Cbl-b promotes cell detachment via ubiquitination of focal adhesion kinase.

Authors:  Yibo Fan; Xiujuan Qu; Yanju Ma; Yunpeng Liu; Xuejun Hu
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

8.  Overexpression of p42.3 promotes cell proliferation, migration, and invasion in human gastric cancer cells.

Authors:  Wen-Jia Cao; Wen-Qi Du; Lin-Lin Mao; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Tumour Biol       Date:  2016-07-23

9.  Effect of p120 catenin silencing on biological behaviors of PANC-1 cells.

Authors:  Zhangjun Cheng; Volker Assfag; Xin Shi; Shibo Lin; Jiangyan Xia; Pinghua Yang; Norbert Hüser; Feng Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

10.  A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.

Authors:  Justin C Brown; Andrea B Troxel; Bonnie Ky; Nevena Damjanov; Babette S Zemel; Michael R Rickels; Andrew D Rhim; Anil K Rustgi; Kerry S Courneya; Kathryn H Schmitz
Journal:  Contemp Clin Trials       Date:  2016-03-10       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.